Natco Pharma News: Read Latest News & Live Updates on Natco Pharma, Photos, Videos at CNBCTV18.com

homeNatco Pharma News

Natco Pharma NEWS

All

india | Apr 17, 2024 3:31 PM IST
Natco Pharma vs FMC Corp: Supreme Court transfers patent infringement suits to Delhi HC
market | Apr 9, 2024 9:57 AM IST
Natco Pharma shares give up gains after USFDA warning letter for Kothur facility
market | Feb 19, 2024 11:51 AM IST
Natco Pharma shares hit new 52-week high after strong earnings
business | Dec 7, 2023 4:03 PM IST
Chennai Floods: Natco Pharma temporarily shuts down API plant in Manali Industrial area
business | Aug 9, 2023 3:42 PM IST
Natco Pharma to invest $3 million to set up wholly-owned subsidiary in the UK
earnings | May 29, 2023 5:33 PM IST
Hyderabad-based Natco Pharma returns to profit in Q4 as business grows in US, Canada
business | Apr 20, 2023 1:42 PM IST
Natco Pharma to set up subsidiary in Indonesia, plans investment up to $3 million
healthcare | Mar 10, 2023 8:58 AM IST
Natco Pharma launches additional strengths of cancer drug Revlimid
market | Mar 8, 2023 12:26 PM IST
Natco Pharma board approves buyback of 30 lakh shares
market | Mar 3, 2023 11:50 AM IST
Natco Pharma board to consider share buyback on March 8 - Shares rise 4%
market | Mar 1, 2023 1:41 PM IST
Natco Pharma launches generic version of cancer treatment drug in Canada
market | Feb 13, 2023 5:15 PM IST
Natco Pharma submits application with USFDA for generic cancer drug
market | Feb 6, 2023 1:17 PM IST
Natco Pharma's Visakhapatnam formulations unit gets two observations from USFDA
market | Dec 6, 2022 1:49 PM IST
Delhi High Court dismisses FMC Corporation appeal in favourable verdict for Natco Pharma
business | Nov 22, 2022 2:17 PM IST
Dr Reddy's faces antitrust litigations in the US over cancer drug Revlimid generic

Natco Pharma NEWS

Natco Pharma vs FMC Corp: Supreme Court transfers patent infringement suits to Delhi HC

Natco Pharma shares give up gains after USFDA warning letter for Kothur facility

Natco Pharma shares hit new 52-week high after strong earnings

Chennai Floods: Natco Pharma temporarily shuts down API plant in Manali Industrial area

Natco Pharma to invest $3 million to set up wholly-owned subsidiary in the UK

Hyderabad-based Natco Pharma returns to profit in Q4 as business grows in US, Canada

Natco Pharma to set up subsidiary in Indonesia, plans investment up to $3 million

Natco Pharma launches additional strengths of cancer drug Revlimid

Natco Pharma board approves buyback of 30 lakh shares

Natco Pharma board to consider share buyback on March 8 - Shares rise 4%

Natco Pharma launches generic version of cancer treatment drug in Canada

Natco Pharma submits application with USFDA for generic cancer drug

Natco Pharma's Visakhapatnam formulations unit gets two observations from USFDA

Delhi High Court dismisses FMC Corporation appeal in favourable verdict for Natco Pharma

Dr Reddy's faces antitrust litigations in the US over cancer drug Revlimid generic